Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00301236
Status:
COMPLETED
Last Update Posted:
2007-12-21
First Post:
2006-03-08
Brief Title:
Efficacy Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-DeficitHyperactivity Disorder
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 5-Week Treatment Multi-Center Double-Blind Randomized Placebo-Controlled Parallel-Group Fixed-Dose Study of the Efficacy Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules Administered Once Daily in Pediatric Children With Attention-DeficitHyperactivity Disorder
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age
Detailed Description:
The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None